Skip to main content
. Author manuscript; available in PMC: 2020 Jul 28.
Published in final edited form as: J Immunol. 2011 Jan 12;186(4):2087–2094. doi: 10.4049/jimmunol.1002340

FIGURE 7.

FIGURE 7.

HCV peptide (C5A) enhancement of OVA-specific cellular immune responses. C57BL/6 mice were immunized i.p. on day 0 with 0.2 ml PBS containing 50 μg OVA in the presence of alum (3 mg), HCV peptide (C5A; 10 μM) or fMLF (1 μM). On day 14, mice were booster-immunized by i.p. injection of 0.2 ml PBS containing 50 μg OVA. Ag-specific T cell proliferation (A) and cytokine production (B) were measured. The data from one of three representative experiments are shown. *p < 0.05 compared with PBS-treated group.